Effects of intraduodenal infusion of L-tryptophan on ad libitum eating, antropyloroduodenal motility, glycemia, insulinemia, and gut peptide secretion in healthy men

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 9, 2014, Pages 3275-3284

  Steinert, Robert E ^a,b   Luscombe Marsh, Natalie D ^b,c   Little, Tanya J ^d   Standfield, Scott ^a,b   Otto, Bärbel ^e   Horowitz, Michael ^a,b   Feinle Bisset, Christine ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL   (Australia)

^c CSIRO   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; GHRELIN; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; PEPTIDE YY; TRYPTOPHAN; ANOREXIGENIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; AMINO ACID ANALYSIS; ANTRAL PRESSURE; ANTROPYLORODUODENAL MOTILITY; ARTICLE; CALORIC INTAKE; CONTROLLED STUDY; CORRELATIONAL STUDY; DECREASED APPETITE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEEDING BEHAVIOR; FOOD INTAKE; GASTROINTESTINAL MOTILITY; GLUCOSE BLOOD LEVEL; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; INSULINEMIA; LOW DRUG DOSE; MALE; NAUSEA; NORMAL HUMAN; OUTCOME ASSESSMENT; PROTEIN SECRETION; PYLORIC PRESSURE; RANDOMIZED CONTROLLED TRIAL; STOMACH PRESSURE; TREATMENT DURATION; ADOLESCENT; BLOOD; DRUG EFFECTS; DUODENUM; EATING; FEEDBACK SYSTEM; PHYSIOLOGY; STOMACH ANTRUM; STOMACH EMPTYING; YOUNG ADULT;

ADOLESCENT; ADULT; APPETITE DEPRESSANTS; BLOOD GLUCOSE; CHOLECYSTOKININ; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DUODENUM; EATING; FEEDBACK, PHYSIOLOGICAL; FEEDING BEHAVIOR; GASTRIC EMPTYING; GASTROINTESTINAL MOTILITY; GLUCAGON; HEALTHY VOLUNTEERS; HUMANS; INSULIN; MALE; PEPTIDE YY; PYLORIC ANTRUM; TRYPTOPHAN; YOUNG ADULT;

EID: 84906051946     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1943     Document Type: Article

References (47)

1. Batterham RL, Heffron H, Kapoor S, et al. Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab. 2006; 4: 223-233.
2. Bowen J, Noakes M, Trenerry C, Clifton PM. Energy intake, ghrelin, and cholecystokinin after different carbohydrate and protein preloads in overweight men. J Clin Endocrinol Metab. 2006; 91: 1477-1483.
3. Lejeune MP, Westerterp KR, Adam TC, Luscombe-Marsh ND, Westerterp-Plantenga MS. Ghrelin and glucagon-like peptide 1 concentrations, 24-h satiety, and energy and substrate metabolism during a high-protein diet and measured in a respiration chamber.AmJ Clin Nutr. 2006; 83: 89-94.
4. Brennan IM, Luscombe-Marsh ND, Seimon RV, et al. Effects of fat, protein, and carbohydrate and protein load on appetite, plasma cholecystokinin, peptide YY, and ghrelin, and energy intake in lean and obese men. Am J Physiol Gastrointest Liver Physiol. 2012; 303: G129-G140.
5. Ma J, Stevens JE, Cukier K, et al. Effects of a protein preload on gastric emptying, glycemia, and gut hormones after a carbohydrate meal in diet-controlled type 2 diabetes. Diabetes Care. 2009; 32: 1600-1602.
6. Tougas G, Anvari M, Dent J, Somers S, Richards D, Stevenson GW. Relation of pyloric motility to pyloric opening and closure in healthy subjects. Gut. 1992; 33: 466-471.
7. Steinert RE, Feinle-Bisset C, Geary N, Beglinger C. Digestive physiology of the pig symposium: Secretion of gastrointestinal hormones and eating control. J Anim Sci. 2013; 91: 1963-1973.
8. Feinle C, O'Donovan D, Doran S, et al. Effects of fat digestion on appetite, APD motility, and gut hormones in response to duodenal fat infusion in humans. Am J Physiol Gastrointest Liver Physiol. 2003; 284: G798-G807.
9. Feltrin KL, Little TJ, Meyer JH, et al. Effects of intraduodenal fatty acids on appetite, antropyloroduodenal motility, and plasma CCK and GLP-1 in humans vary with their chain length. Am J Physiol Regul Integr Comp Physiol. 2004; 287: R524-R533.
10. Kalogeropoulou D, Lafave L, Schweim K, Gannon MC, Nuttall FQ. Leucine, when ingested with glucose, synergistically stimulates insulin secretion and lowers blood glucose. Metabolism. 2008; 57: 1747-1752.
11. Layman DK, Walker DA. Potential importance of leucine in treatment of obesity and the metabolic syndrome. J Nutr. 2006; 136: 319S-323S.
12. Chang J, Wu T, Greenfield JR, Samocha-Bonet D, Horowitz M, Rayner CK. Effects of intraduodenal glutamine on incretin hormone and insulin release, the glycemic response to an intraduodenal glucose infusion, and antropyloroduodenal motility in health and type 2 diabetes. Diabetes Care. 2013; 36: 2262-2265.
13. Greenfield JR, Farooqi IS, Keogh JM, et al. Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects. Am J Clin Nutr. 2009; 89: 106-113.
14. Ballinger A, McLoughlin L, Medbak S, Clark M. Cholecystokinin is a satiety hormone in humans at physiological post-prandial plasma concentrations. Clin Sci. 1995; 89: 375-381.
15. Carney BI, Jones KL, HorowitzM,SunWM,Hebbard G, Edelbroek MA. Stereospecific effects of tryptophan on gastric emptying and hunger in humans. J Gastroenterol Hepatol. 1994; 9: 557-563.
16. Hrboticky N, Leiter LA, Anderson GH. Effects of L-Tryptophan on short term food intake in lean men. Nutr Res. 1985; 5: 595-607.
17. Nieuwenhuizen AG, Hochstenbach-Waelen A, Veldhorst MA, et al. Acute effects of breakfasts containing-lactalbumin, or gelatin with or without added tryptophan, on hunger, 'satiety' hormones and amino acid profiles. Br J Nutr. 2009; 101: 1859-1866.
18. Little TJ, Feltrin KL, HorowitzM,et al. Dose-related effects of lauric acid on antropyloroduodenal motility, gastrointestinal hormone release, appetite, and energy intake in healthy men.AmJ Physiol Regul Integr Comp Physiol. 2005; 289: R1090-R1098.
19. Stunkard AJ, Messick S. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res. 1985; 29: 71-83.
20. Heddle R, Dent J, Toouli J, Read NW. Topography and measurement of pyloric pressure waves and tone in humans. Am J Physiol. 1988; 255: G490-G497.
21. Nair NS, Brennan IM, Little TJ, et al. Reproducibility of energy intake, gastric emptying, blood glucose, plasma insulin and cholecystokinin responses in healthy young males. Br J Nutr. 2009; 101: 1094-1102.
22. Parker BA, Sturm K, MacIntosh CG, Feinle C, Horowitz M, Chapman IM. Relation between food intake and visual analogue scale ratings of appetite and other sensations in healthy older and young subjects. Eur J Clin Nutr. 2004; 58: 212-218.
23. Ryan AT, Feinle-Bisset C, Kallas A, et al. Intraduodenal protein modulates antropyloroduodenal motility, hormone release, glycemia, appetite, and energy intake in lean men. Am J Clin Nutr. 2012; 96: 474-482.
24. Santangelo A, Peracchi M, Conte D, Fraquelli M, Porrini M. Physical state of meal affects gastric emptying, cholecystokinin release and satiety. Br J Nutr. 1998; 80: 521-527.
25. Camilleri M, Malagelada JR. Abnormal intestinal motility in diabetics with the gastroparesis syndrome. Eur J Clin Invest. 1984; 14: 420-427.
26. Bland JM, Altman DG. Calculating correlation coefficients with repeated observations: part 1-correlation within subjects. BMJ. 1995; 310: 446.
27. Brennan IM, Little TJ, Feltrin KL, et al. Dose-dependent effects of cholecystokinin-8 on antropyloroduodenal motility, gastrointestinal hormones, appetite, and energy intake in healthy men. Am J Physiol Endocrinol Metab. 2008; 295: E1487-E1494.
28. Geary N, Kissileff HR, Pi-Sunyer FX, Hinton V. Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men. Am J Physiol. 1992; 262: R975-R980.
29. Pilichiewicz AN, Chaikomin R, Brennan IM, et al. Load-dependent effects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy men. Am J Physiol Endocrinol Metab. 2007; 293: E743-E753.
30. Brubaker PL, Anini Y. Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2. Can J Physiol Pharmacol. 2003; 81: 1005-1012.
31. Adibi SA, Mercer DW. Protein digestion in human intestine as reflected in luminal, mucosal, and plasma amino acid concentrations after meals. J Clin Invest. 1973; 52: 1586-1594.
32. Edelbroek M, Sun WM, Horowitz M, Dent J, Smout A, Akkermans L. Stereospecific effects of intraduodenal tryptophan on pyloric and duodenal motility in humans. Scand J Gastroenterol. 1994; 29: 1088-1095.
33. Seimon RV, Lange K, Little TJ, et al. Pooled-data analysis identifies pyloric pressures and plasma cholecystokinin concentrations as major determinants of acute energy intake in healthy, lean men. Am J Clin Nutr. 2010; 92: 61-68.
34. Mellinkoff SM, Frankland M, Boyle D, Greipel M. Relationship between serum amino acid concentration and fluctuations in appetite. J Appl Physiol. 1956; 8: 535-538.
35. Hall WL, Millward DJ, Long SJ, Morgan LM. Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite. Br J Nutr. 2003; 89: 239-248.
36. Uhe AM, Collier GR, O'Dea K. A comparison of the effects of beef, chicken and fish protein on satiety and amino acid profiles in lean male subjects. J Nutr. 1992; 122: 467-472.
37. Jordi J, Herzog B, Camargo SM, Boyle CN, Lutz TA, Verrey F. Specific amino acids inhibit food intake via the area postrema or vagal afferents. J Physiol. 2013; 591: 5611-5621.
38. Cota D, Proulx K, Smith KA, et al. Hypothalamic mTOR signaling regulates food intake. Science. 2006; 312: 927-930.
39. Halford JC, Harrold JA, Lawton CL, Blundell JE. Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity. Curr Drug Targets. 2005; 6: 201-213.
40. Tessari P, Kiwanuka E, Cristini M, et al. Slow versus fast proteins in the stimulation of-cell response and the activation of the enteroinsular axis in type 2 diabetes. Diabetes Metab Res Rev. 2007; 23: 378-385.
41. Little TJ, Doran S, Meyer JH, et al. The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposed.AmJ Physiol Endocrinol Metab. 2006; 291: E647-E655.
42. Pilichiewicz AN, Little TJ, Brennan IM, et al. Effects of load, and duration, of duodenal lipid on antropyloroduodenal motility, plasma CCK and PYY, and energy intake in healthy men. Am J Physiol Regul Integr Comp Physiol. 2006; 290: R668-R677.
43. Williams DL, Cummings DE, Grill HJ, Kaplan JM. Meal-related ghrelin suppression requires postgastric feedback. Endocrinology. 2003; 144: 2765-2767.
44. Steinert RE, Meyer-Gerspach AC, Beglinger C. The role of the stomach in the control of appetite and the secretion of satiation peptides. Am J Physiol Endocrinol Metab. 2012; 302: E666-E673.
45. Parker BA, Doran S, Wishart J, Horowitz M, Chapman IM. Effects of small intestinal and gastric glucose administration on the suppression of plasma ghrelin concentrations in healthy older men and women. Clin Endocrinol (Oxf). 2005; 62: 539-546.
46. Hass N, Schwarzenbacher K, Breer H. T1R3 is expressed in brush cells and ghrelin-producing cells of murine stomach. Cell Tissue Res. 2010; 339: 493-504.
47. Widmayer P, KüperM,KramerM,Königsrainer A, Breer H. Altered expression of gustatory-signaling elements in gastric tissue of morbidly obese patients. Int J Obes (Lond). 2012; 36: 1353-1359.